Panorama is a blood-based genetic, prenatal screening test of the pregnant mom that screens for common chromosomal conditions that affect a baby’s health. Panorama uses unique SNP*-based technology to deliver the most accurate NIPT on the market. Learn
The article reports that San Carlos, California-based Natera has completed a 54.6 million dollar financing round to support the expansion and global rollout of its non-invasive prenatal test called Panorama in 2013. New and existing investors that participated in the financing round include OrbiMed ...
It is especially counter-intuitive when interpreting a positive result in a test on a low-incidence population after having dealt with positive results drawn from a high-incidence population.[2] If the false positive rate of the test is higher than the proportion of the new population with the...